When your rally enthusiast car pals are dissecting the most recent race, they may mention “anti-lag” in their banter. You vaguely realize it’s associated with the epic, fiery exhaust pops ...

Meredith McKean, MD, MPH, discusses the background and goals from the recent long-term follow-up of a phase 1 study evaluating the combination of fianlimab and cemiplimab in advanced melanoma.

Turbo lag can seriously put a damper on a car's fun factor, so several automakers have worked to create their own anti-lag systems. Turbocharged performance comes with a downside. The following ...

MSD has decided to abandon the development of its anti-TIGIT antibody vibostolimab and anti-LAG-3 antibody favezelimab, blowing a hole in its immuno-oncology pipeline. The demise of the two ...